Looks good on the surface but if you re-read the announcement it...

Looks good on the surface but if you re-read the announcement it says:

"Specifically, in December 2004, Solbec commissioned RT to screen Coramsine’s® anti-cancer activity against up to 72 human tumour samples via ex-vivo analysis. In addition to this work Solbec have continued to provide Coramsine compound to Dr Nagourney at RT for their ongoing cancer screening program."

"The Physician’s IND is being made on the basis that the specific patient’s tumour has shown ex-vivo sensitivity to Coramsine where other conventional chemotherapeutics have failed."

So in 2004 Solbec did work with RT and have continued providing Coramsine in the three years since. But only now has one patient shown sensitivity where other conventional treatments have failed. Dr Robert Nagourney runs one of the biggest cancer screening and treatment centres on the West Coast so why hasn't more patients been identified as being suitable for Cormasine over the last three years? We need more information about this announcement and exactly what RT have been doing before making too much of this last announcement.